Prediction of Myocardial Infarction Versus Cardiac Death by Gated Myocardial Perfusion SPECT: Risk Stratification by the Amount of Stress-Induced Ischemia and the Poststress Ejection Fraction
Tali Sharir,
Guido Germano,
Xingping Kang,
Howard C. Lewin,
Romalisa Miranda,
Ishac Cohen,
Raluca D. Agafitei,
John D. Friedman and
Daniel S. Berman
Division of Nuclear Medicine, Department of Imaging, and Division of Cardiology, Department of Medicine, Burns and Allen Research Institute, Cedars-Sinai Medical Center, Los Angeles; and Department of Medicine, University of California, Los Angeles, School of Medicine, Los Angeles, California

View larger version (18K):
[in a new window]
|
FIGURE 1. Univariate (A and B) and multivariate (C) Cox regression analysis for prediction of CD and nonfatal MI. LK = prescan likelihood of coronary disease; DM = diabetes mellitus. *P < 0.02. **P < 0.001.
|
|

View larger version (13K):
[in a new window]
|
FIGURE 2. Annual CD rate as function of EF. Number of patients at each 10% interval is indicated in parentheses.
|
|

View larger version (13K):
[in a new window]
|
FIGURE 3. Cumulative survival with stratification by EF. Number of patients in each subgroup is indicated.
|
|

View larger version (11K):
[in a new window]
|
FIGURE 4. Nonfatal MI rate as function of SDS. Number of patients at each 5-unit interval is indicated.
|
|

View larger version (13K):
[in a new window]
|
FIGURE 5. Cumulative hazard of nonfatal MI with stratification by presence or absence of ischemia. Number of patients in each subgroup is indicated.
|
|

View larger version (19K):
[in a new window]
|
FIGURE 6. CD rate as function of amount of ischemia in patients with EF >50% and EF between 30% and 50% (A) and in patients with EF <30% (B). Mod = moderate. *P < 0.05 vs. EF >50% in same perfusion category. **P < 0.005 compared with no ischemia and same EF category.
|
|

View larger version (24K):
[in a new window]
|
FIGURE 7. Risk stratification by poststress EF and amount of stress-induced ischemia.
|
|
Copyright © 2001 by the Society of Nuclear Medicine.